Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis

Hypertension Research

Volumn 24, Issue 5, 2001, Pages 595-598

  Kojima, S ^a   Shida, M ^a   Takano, H ^a   Inami, S ^a   Yodogawa, K ^a   Yokoyama, H ^a   Kuramochi, M ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin receptors; Bradykinin; LDL apheresis

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR; ANGIOTENSIN TYPE 2 RECEPTOR; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BRADYKININ; DEXTRAN SULFATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HUMORAL ANTIBODY; IMIDAPRIL; LOSARTAN; LOW DENSITY LIPOPROTEIN; NAFAMSTAT MESILATE; TANATORIL; UNCLASSIFIED DRUG;

ADULT; ANAPHYLAXIS; ANGIOTENSIN BLOOD LEVEL; APHERESIS; ARTICLE; BLOOD PRESSURE; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CASE REPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; HYPERTENSION; HYPOTENSION; LACRIMATION; MALE; VISUAL IMPAIRMENT;

ALDOSTERONE; ANAPHYLAXIS; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD COMPONENT REMOVAL; BLOOD PRESSURE; BRADYKININ; CHOLESTEROL, LDL; HUMANS; HYPOTENSION; LOSARTAN; MALE; MIDDLE AGED; OLIGOPEPTIDES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN;

EID: 0035163228     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.24.595     Document Type: Article

References (18)

1. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial
2. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
3. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia
4. Dextran sulphate activation of the contact system in plasma and ascites
5. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column
6. Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitor
7. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril malate in patients with essential hypertension
8. Losartan improves diastolic ventricular filling of hypertensive patients with diastolic dysfunction
9. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis
10. A possible mechanism of hypotension during LDL apheresis in patients taking ACE inhibitors
11. A sensitive radioimmunoassay for the determination of plasma angiotensin II in human subjects
12. LDL apheresis with dextran sulfate and angiotensin receptor antagonist (losartan)
13. Use of losartan in FH patients during treatment with DSC-LDL apheresis
14. Measurement of circulating kinins, their changes by inhibition of kininase II and their possible blood pressure lowering effect
15. Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension
16. 2 receptors in the developing rat fetus
17. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
18. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation